Cargando…

The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study

BACKGROUND: Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fajfr, Miroslav, Louda, Miroslav, Paterová, Pavla, Ryšková, Lenka, Pacovský, Jaroslav, Košina, Josef, Žemličková, Helena, Broďák, Miloš
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406914/
https://www.ncbi.nlm.nih.gov/pubmed/28446177
http://dx.doi.org/10.1186/s12894-017-0222-6
_version_ 1783232062501683200
author Fajfr, Miroslav
Louda, Miroslav
Paterová, Pavla
Ryšková, Lenka
Pacovský, Jaroslav
Košina, Josef
Žemličková, Helena
Broďák, Miloš
author_facet Fajfr, Miroslav
Louda, Miroslav
Paterová, Pavla
Ryšková, Lenka
Pacovský, Jaroslav
Košina, Josef
Žemličková, Helena
Broďák, Miloš
author_sort Fajfr, Miroslav
collection PubMed
description BACKGROUND: Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic. METHOD: In this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were used for the antibiotic susceptibility evaluation. RESULTS: The most frequently tested bacterial isolates were Escherichia coli (51.3%, n = 1703), Klebsiella pneumoniae (19.4%, n = 643) and Proteus spp. (11.8%, n = 392). Among all isolates 29.0% (n = 963) were resistant to fluoroquinolones, 11.3% (n = 374) produced extended spectrum β-lactamase and 4.2% (n = 141) produced AmpC β-lactamase. The overall in vitro susceptibility was significantly higher for fosfomycin compared to the other tested per-oral antibiotics (nitrofurantoin, ampicillin, co-trimoxazole, ciprofloxacin and cefuroxime) against all tested Gram-negative rod isolates (excluding Morganella morgani and Acinetobacter spp. isolates). Fosfomycin also remained highly active against those isolates with extended spectrum β-lactamase (ESBL) production (95.8% in Escherichia coli isolates and 85.3% in Klebsiella pneumoniae isolates), unlike other tested per-oral antibiotics, which showed significant (p < 0.0001) susceptibility decrease. CONCLUSION: We have confirmed in the Czech Republic the very high susceptibility to fosfomycin trometamol of urinary tract infection pathogens, particularly Gram-negative rods including those producing β-lactamase.
format Online
Article
Text
id pubmed-5406914
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54069142017-04-27 The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study Fajfr, Miroslav Louda, Miroslav Paterová, Pavla Ryšková, Lenka Pacovský, Jaroslav Košina, Josef Žemličková, Helena Broďák, Miloš BMC Urol Research Article BACKGROUND: Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic. METHOD: In this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were used for the antibiotic susceptibility evaluation. RESULTS: The most frequently tested bacterial isolates were Escherichia coli (51.3%, n = 1703), Klebsiella pneumoniae (19.4%, n = 643) and Proteus spp. (11.8%, n = 392). Among all isolates 29.0% (n = 963) were resistant to fluoroquinolones, 11.3% (n = 374) produced extended spectrum β-lactamase and 4.2% (n = 141) produced AmpC β-lactamase. The overall in vitro susceptibility was significantly higher for fosfomycin compared to the other tested per-oral antibiotics (nitrofurantoin, ampicillin, co-trimoxazole, ciprofloxacin and cefuroxime) against all tested Gram-negative rod isolates (excluding Morganella morgani and Acinetobacter spp. isolates). Fosfomycin also remained highly active against those isolates with extended spectrum β-lactamase (ESBL) production (95.8% in Escherichia coli isolates and 85.3% in Klebsiella pneumoniae isolates), unlike other tested per-oral antibiotics, which showed significant (p < 0.0001) susceptibility decrease. CONCLUSION: We have confirmed in the Czech Republic the very high susceptibility to fosfomycin trometamol of urinary tract infection pathogens, particularly Gram-negative rods including those producing β-lactamase. BioMed Central 2017-04-26 /pmc/articles/PMC5406914/ /pubmed/28446177 http://dx.doi.org/10.1186/s12894-017-0222-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Fajfr, Miroslav
Louda, Miroslav
Paterová, Pavla
Ryšková, Lenka
Pacovský, Jaroslav
Košina, Josef
Žemličková, Helena
Broďák, Miloš
The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study
title The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study
title_full The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study
title_fullStr The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study
title_full_unstemmed The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study
title_short The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study
title_sort susceptibility to fosfomycin of gram-negative bacteria isolates from urinary tract infection in the czech republic: data from a unicentric study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406914/
https://www.ncbi.nlm.nih.gov/pubmed/28446177
http://dx.doi.org/10.1186/s12894-017-0222-6
work_keys_str_mv AT fajfrmiroslav thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT loudamiroslav thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT paterovapavla thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT ryskovalenka thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT pacovskyjaroslav thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT kosinajosef thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT zemlickovahelena thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT brodakmilos thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT fajfrmiroslav susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT loudamiroslav susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT paterovapavla susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT ryskovalenka susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT pacovskyjaroslav susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT kosinajosef susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT zemlickovahelena susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy
AT brodakmilos susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy